Literature DB >> 15507648

Epstein-Barr virus infection in ex vivo tonsil epithelial cell cultures of asymptomatic carriers.

Dirk M Pegtel1, Jaap Middeldorp, David A Thorley-Lawson.   

Abstract

Epstein-Barr virus (EBV) is found frequently in certain epithelial pathologies, such as nasopharyngeal carcinoma and oral hairy leukoplakia, indicating that the virus can infect epithelial cells in vivo. Recent studies of cell lines imply that epithelial cells may also play a role in persistent EBV infection in vivo. In this report, we show the establishment and characterization of an ex vivo culture model of tonsil epithelial cells, a likely site for EBV infection in vivo. Primary epithelial-cell cultures, generated from tonsil explants, contained a heterogeneous mixture of cells with an ongoing process of differentiation. Keratin expression profiles were consistent with the presence of cells from both surface and crypt epithelia. A small subset of cells could be latently infected by coculture with EBV-releasing cell lines, but not with cell-free virus. We also detected viral-DNA, -mRNA, and -protein expression in cultures from EBV-positive tonsil donors prior to in vitro infection. We conclude that these cells were either already infected at the time of explantation or soon after through cell-to-cell contact with B cells replicating EBV in the explant. Taken together, these findings suggest that the tonsil epithelium of asymptomatic virus carriers is able to sustain EBV infection in vivo. This provides an explanation for the presence of EBV in naso- and oropharyngeal pathologies and is consistent with epithelial cells playing a role in the egress of EBV during persistent infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507648      PMCID: PMC525079          DOI: 10.1128/JVI.78.22.12613-12624.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of EBV-infected cells.

Authors:  G Niedobitek; A Agathanggelou; H Herbst; L Whitehead; D H Wright; L S Young
Journal:  J Pathol       Date:  1997-06       Impact factor: 7.996

2.  EBV persistence in memory B cells in vivo.

Authors:  G J Babcock; L L Decker; M Volk; D A Thorley-Lawson
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

Review 3.  Immunology of the tonsils.

Authors:  M Perry; A Whyte
Journal:  Immunol Today       Date:  1998-09

4.  Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells.

Authors:  S Imai; J Nishikawa; K Takada
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Active replication of HIV-1 at the lymphoepithelial surface of the tonsil.

Authors:  S S Frankel; K Tenner-Racz; P Racz; B M Wenig; C H Hansen; D Heffner; A M Nelson; M Pope; R M Steinman
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

6.  Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals.

Authors:  M A Karajannis; M Hummel; I Anagnostopoulos; H Stein
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

7.  The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance.

Authors:  M E Perry
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

8.  A limited role for retinoic acid and retinoic acid receptors RAR alpha and RAR beta in regulating keratin 19 expression and keratinization in oral and epidermal keratinocytes.

Authors:  M Schön; J G Rheinwald
Journal:  J Invest Dermatol       Date:  1996-09       Impact factor: 8.551

9.  Epstein-Barr virus infection in non-carcinomatous gastric epithelium.

Authors:  H Yanai; K Takada; N Shimizu; Y Mizugaki; M Tada; K Okita
Journal:  J Pathol       Date:  1997-11       Impact factor: 7.996

10.  fyn tyrosine kinase is involved in keratinocyte differentiation control.

Authors:  E Calautti; C Missero; P L Stein; R M Ezzell; G P Dotto
Journal:  Genes Dev       Date:  1995-09-15       Impact factor: 11.361

View more
  51 in total

1.  Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals.

Authors:  Giao T Huynh; Libin Rong
Journal:  J Theor Biol       Date:  2012-06-07       Impact factor: 2.691

2.  Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL.

Authors:  Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 3.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

4.  Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells.

Authors:  Susan M Turk; Ru Jiang; Liudmila S Chesnokova; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.

Authors:  R Jiang; R S Scott; L M Hutt-Fletcher
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

6.  The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.

Authors:  Timothy R Geiger; Jennifer M Martin
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

7.  Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.

Authors:  Chia Chi Sun; David A Thorley-Lawson
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

8.  Epstein-Barr virus transcytosis through polarized oral epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Joel M Palefsky
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

9.  Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells.

Authors:  Liguo Wu; Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 10.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.